Related references
Note: Only part of the references are listed.Extracellularly secreted APE1/Ref-1 triggers apoptosis in triple-negative breast cancer cells via RAGE binding, which is mediated through acetylation
Yu Ran Lee et al.
ONCOTARGET (2015)
APE1/Ref-1 as a Seroloqical Biomarker for the Detection of Bladder Cancer
Ju Hyun Shin et al.
CANCER RESEARCH AND TREATMENT (2015)
Human Apurinic/Apyrimidinic Endonuclease 1
Mengxia Li et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
R. T. Bryan et al.
BRITISH JOURNAL OF CANCER (2014)
Histone deacetylases inhibitor trichostatin A modulates the extracellular release of APE1/Ref-1
Sunga Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests
Steve Goodison et al.
MOLECULAR DIAGNOSIS & THERAPY (2013)
Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer
Nan Dai et al.
PLOS ONE (2013)
Cancer treatment and survivorship statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
IL-8 as a urinary biomarker for the detection of bladder cancer
Virginia Urquidi et al.
BMC UROLOGY (2012)
Identification of Three New Autoantibodies Associated with Systemic Lupus Erythematosus Using Two Proteomic Approaches
Yasuhiro Katsumata et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008
Kyu-Won Jung et al.
CANCER RESEARCH AND TREATMENT (2011)
Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival
Birgitte V. Offersen et al.
ACTA ONCOLOGICA (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Alteration of APEI/ref-1 expression in non-small cell lung cancer: The implications of impaired extracellular superoxide dismutase and catalase antioxidant systems
Dae Goon Yoo et al.
LUNG CANCER (2008)
Urine proteomics: the present and future of measuring urinary protein components in disease
Jonathan Barratt et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review
RJ Hung et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Estimation of the Youden index and its associated cutoff point
R Fluss et al.
BIOMETRICAL JOURNAL (2005)
Establishment of a near-standard two-dimensional human urine proteomic map
J Oh et al.
PROTEOMICS (2004)
False-positive results of the NMP22 test due to hematuria
N Atsü et al.
JOURNAL OF UROLOGY (2002)
The BTA STAT test is nonspecific for hematuria: An experimental hematuria model
O Oge et al.
JOURNAL OF UROLOGY (2002)
Primary superficial bladder cancer risk groups according to progression, mortality and recurrence
F Millan-Rodriguez et al.
JOURNAL OF UROLOGY (2000)
Share Paper
